Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer - EurekAlert!
Mayo Clinic study finds chemotherapy before surgery improves survival in early-stage pancreatic cancer - EurekAlert!
Study identifies PARG as a new target to enhance chemotherapy in colorectal cancer - EurekAlert!
Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy - EurekAlert!
Chemotherapy rewires gut bacteria to block metastasis
A Hidden Effect of Chemotherapy Could Help Block Metastasis
World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments - EurekAlert!
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease - EurekAlert!
Nanocarrier-mediated cancer therapy: New advances in immunotherapy, chemotherapy, and radiotherapy - EurekAlert!
Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting - EurekAlert!
A drug already in trials may stop chemotherapy nerve damage
A cysteine-rich diet may promote regeneration of the intestinal lining, study suggests: The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.
New study links genetic variation to chemotherapy-related liver damage in patients with colorectal cancer liver metastases - EurekAlert!
How does chemotherapy disrupt circadian rhythms? - EurekAlert!
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC - EurekAlert!
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC - EurekAlert!
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study - EurekAlert!
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy - EurekAlert!
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC - EurekAlert!
New cancer drug boosts effectiveness of chemotherapy – even in resistant tumours - EurekAlert!
